https://www.selleckchem.com/products/sw033291.html
Human embryonic stem cells (hESC) as a source for the development of advanced therapy medicinal products are considered for treatment of Parkinson's disease (PD). Research has shown promising results and opened an avenue of great importance for patients who currently lack a disease modifying therapy. The use of hESC has given rise to moral concerns and been the focus of often heated debates on the moral status of human embryos. Approval for marketing is still pending. To Investigate the perspectives and concerns of patients with PD, pa
Me gusta
Comentario
Compartir
